CCA
BSX icon

Childress Capital Advisors’s Boston Scientific BSX Stock Holding History

Childress Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$239K Sell
3,802
-2,890
-43% -$231K 0.04% 322
2025
Q4 		$638K Buy
6,692
+93
+1% +$9.12K 0.1% 147
2025
Q3 		$644K Buy
6,599
+272
+4% +$28.2K 0.12% 128
2025
Q2 		$680K Buy
6,327
+264
+4% +$26.7K 0.17% 91
2025
Q1 		$612K Sell
6,063
-138
-2% -$13.9K 0.18% 83
2024
Q4 		$554K Buy
6,201
+350
+6% +$30.8K 0.15% 89
2024
Q3 		$490K Buy
5,851
+106
+2% +$8.36K 0.13% 114
2024
Q2 		$442K Sell
5,745
-164
-3% -$12K 0.12% 114
2024
Q1 		$405K Sell
5,909
-764
-11% -$49.1K 0.12% 112
2023
Q4 		$386K Buy
6,673
+169
+3% +$9.02K 0.12% 111
2023
Q3 		$343K Buy
+6,504
New +$341K 0.11% 108
2023
Q1 		– Sell
-6,201
Closed -$287K – 101
2022
Q4 		$287K Buy
6,201
+212
+4% +$9.18K 0.1% 136
2022
Q3 		$236K Buy
5,989
+615
+11% +$24.7K 0.09% 143
2022
Q2 		$200K Buy
5,374
+71
+1% +$2.89K 0.08% 162
2022
Q1 		$234K Buy
+5,303
New +$230K 0.08% 164
2021
Q1 		– Sell
-1,358
Closed -$49K – 272
2020
Q4 		$49K Buy
+1,358
New +$48.9K 0.03% 225

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Childress Capital Advisors's BSX Position: Q1 2026 in Review

Childress Capital Advisors reduced its Boston Scientific (BSX) stake by 43% in Q1 2026, selling an estimated $231K and leaving 3,802 shares worth $239K. The position accounts for 0.04% of the portfolio, ranked #322.

Childress Capital Advisors first reported a position in BSX in Q4 2020 and has held it in 16 quarters since. The position peaked at $680K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Childress Capital Advisors held 3,802 shares of Boston Scientific worth $239K as of Q1 2026.
  • Childress Capital Advisors sold 2,890 Boston Scientific shares in Q1 2026, an estimated $231K.
  • Boston Scientific made up 0.04% of Childress Capital Advisors's portfolio in Q1 2026, its #322 holding.
  • Childress Capital Advisors first reported a position in Boston Scientific in Q4 2020 and has held it in 16 quarters since.
  • Childress Capital Advisors's Boston Scientific position peaked at $680K in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Childress Capital Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.